![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessCharacterization of HIV variants from paired Cerebrospinal fluid and Plasma samples in primary microglia and CD4+ T-cells
Despite antiretroviral therapy (ART), HIV persistence in the central nervous system (CNS) continues to cause a range of cognitive impairments in people living with HIV (PLWH). Upon disease progression, transmi...
-
Article
Open AccessDirecting HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies
While vaccination against HIV-1 has been so far unsuccessful, recently broadly neutralizing antibodies (bNAbs) against HIV-1 envelope glycoprotein were shown to induce long-term suppression in the absence of a...
-
Article
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial
There is no cure for HIV infection, and lifelong antiretroviral therapy (ART) is required. N-803 is an IL-15 superagonist comprised of an N72D mutant IL-15 molecule attached to its alpha receptor and a human I...
-
Article
Open AccessHuman microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses
HIV persistence in the CNS despite antiretroviral therapy may cause neurological disorders and poses a critical challenge for HIV cure. Understanding the pathobiology of HIV-infected microglia, the main viral ...
-
Reference Work Entry In depth
Overcoming the Transcriptional Block: The HIV-1 Tat Auxiliary Protein
-
Article
Open AccessProceedings of the Frontiers of Retrovirology Conference 2016
Oral presentations
-
Living Reference Work Entry In depth
Overcoming the Transcriptional Block: The HIV-1 Tat Auxiliary Protein
-
Article
Open AccessPost transcriptional regulation of HIV-1 gene expression by MATR3, PSF and Rev